NextFin News - Seven years after Occidental Petroleum outbid Chevron for Anadarko Petroleum in a $57 billion bet that nearly broke the company, the Houston driller has finally reached the far side of its balance-sheet reckoning. Occidental closed the sale of its OxyChem chemicals unit to Berkshire Hathaway for $9.7 billion in cash on Jan. 2, 2026, and by the second quarter had cut principal debt to $11.8 billion — the lowest level since the second quarter of 2019, before the Anadarko deal closed. The question now is whether a company that spent most of the decade repairing one acquisition has priced in the cost of the next one.
The cleanup is real, and it is measurable. Since closing its $12 billion takeover of Permian producer CrownRock in August 2024, Occidental has repaid roughly $15.6 billion of principal debt, according to S&P Global Ratings. In the first quarter of 2026 alone it retired $7.1 billion of principal. Free cash flow hit about $3 billion in the second quarter of 2026, the strongest since the third quarter of 2022, and the board lifted the dividend 8% to 28 cents a share. Shares have responded: Occidental is up about 38% in 2026, trading near $61.30 with a market capitalization of roughly $61.3 billion as of Aug. 21.
But the Anadarko hangover did not vanish with the debt paydown. Berkshire Hathaway still holds an 8%-dividend preferred stake that must be redeemed out of excess cash before shareholders see buybacks, and the redemption carries a 10% premium. OxyChem, which generated $595 million of pre-tax income in the first three quarters of 2025, is gone — leaving Occidental a purer, and more exposed, oil-and-gas bet. And the architect of the turnaround, chief executive Vicki Hollub, handed the job to chief operating officer Richard Jackson on June 1, 2026. The balance sheet is no longer the story. Execution is.
The Deal That Defined a Decade
Occidental's modern history divides cleanly into before and after Anadarko. On May 9, 2019, the company agreed to pay $59 a share in cash plus 0.2934 Occidental shares for each Anadarko share — a transaction valued at $57 billion including assumed debt, and a decisive escalation in a bidding war Chevron had opened with a $33 billion offer. Berkshire Hathaway supplied the firepower: a $10 billion preferred-equity commitment that let Occidental sweeten its cash offer to roughly 80% of the purchase price. The acquisition closed on Aug. 8, 2019, valued at $55 billion including Anadarko's debt.
The price of that financing was steep and structurally awkward. The preferred stock accrues dividends at 8% a year — 9% on any accrued and unpaid dividends — and its redemption is mandatory when the company generates excess cash or sells assets, with every dollar returned to common shareholders matched by an equal redemption of Berkshire's preferred at a 10% premium. In effect, Berkshire bought a senior claim on Occidental's free cash flow with an equity kicker: warrants to purchase 80 million common shares. For years, that structure sat on the balance sheet like a second mortgage, compressing the multiple investors were willing to pay for the common stock.
The deal also left behind a trail of accounting scars. In May 2020, as crude collapsed, Occidental took a $1.4 billion writedown tied to a pipeline-affiliate investment and withdrew its guidance; by the second quarter it had booked impairment charges of roughly $6.6 billion and posted a net loss of $8.4 billion. The company's market capitalization fell to a fraction of its pre-deal level, and in the years immediately after the acquisition its stock traded near its lowest levels in more than two decades. The Anadarko assets were real — vast Permian acreage, much of it in the Delaware Basin — but the price paid for them had assumed an oil market that disappeared for a time, and the bill came due in the form of debt service, impairments, and a discounted share price.
Hollub, who became chief executive in 2016, spent the better part of seven years reversing the sequence. The strategy was simple to state and difficult to execute: sell the non-core assets, keep the Permian crown jewels, and let high oil prices do the heavy lifting on the debt. Between July 2024 and August 2025 alone, Occidental repaid $7.5 billion of debt. Divestitures announced since the CrownRock deal was first floated in December 2023 total about $4 billion, including an $818 million sale of Delaware Basin assets to Permian Resources in July 2024 and four further Permian dispositions worth roughly $950 million announced in August 2025.
The OxyChem Sale: Cleaning Up the Balance Sheet, Losing a Hedge
The OxyChem transaction, announced on Oct. 2, 2025 and closed on Jan. 2, 2026, was the capstone of that strategy — and its clearest trade-off. Berkshire paid $9.7 billion in cash for the chemicals business, its largest acquisition since it bought Allegheny Corporation for $11.6 billion in 2022. Occidental earmarked $6.5 billion of after-tax proceeds for accelerated debt retirement, a move that carried it to its $15 billion gross-debt target well ahead of the 2029 timeframe analysts had expected. HSBC, which upgraded the stock to Buy from Hold and raised its price target to $55 from $48, framed it plainly: the sale "unfetters the balance sheet."
But the deal also removed Occidental's only meaningful earnings hedge. OxyChem produces chlorine, caustic soda and other basic chemicals whose demand cycle does not move in lockstep with crude oil. The unit contributed $595 million of pre-tax income in the first three quarters of 2025, and even as Occidental lowered its full-year 2025 forecast for the business by about 15% — to a range of $800 million to $900 million, citing a market surplus — that income was stable, contract-like cash flow sitting alongside volatile wellhead revenue. Its second-quarter 2026 midstream and marketing adjusted earnings of roughly $960 million, a quarterly record, now carry more of the diversification burden.
The irony is not lost on observers. Berkshire, already Occidental's largest shareholder with roughly 28% of the common equity as of the deal's announcement, now owns OxyChem outright while still holding the preferred claim on the parent. Doug Leggate of Wolfe Research called it a double win for Berkshire: the chemicals business can run as a strong stand-alone, while the debt paydown it funds should lift the value of Berkshire's remaining stake in Occidental. For Occidental's common holders, the arithmetic is less symmetrical. The company has swapped a diversified earnings stream for a cleaner capital structure — a rational choice for a balance sheet under pressure, but one that leaves shareholders holding a single, concentrated risk: the oil price.
What the Numbers Actually Say About the Turnaround
The financial improvement is not cosmetic. Occidental's principal debt fell from about $27 billion after the CrownRock closing to $13.3 billion by early May 2026, then to $11.8 billion at the end of the second quarter — a level not seen since before the Anadarko closing. Net principal debt stood at $7.6 billion against $4.2 billion of unrestricted cash. Interest expense is down about $630 million on an annualized basis compared with 2025, a direct function of retiring high-coupon debt issued during the acquisition boom.
Cash generation has kept pace. Second-quarter production averaged 1.43 million barrels of oil equivalent a day, exceeding the midpoint of guidance by 23,000 boe/d. Domestic lease operating expense came in at $7.80 per boe, 6% better than guidance. Adjusted earnings were $2.40 a diluted share; reported earnings were $2.75. Full-year capital spending guidance held at $5.5 billion to $5.9 billion, and the company says it remains on track to deliver more than $1.2 billion of free-cash-flow improvement for 2026 before the benefit of higher oil prices.
The dividend tells its own story. At 28 cents a share, payable Oct. 15, 2026, the quarterly payout yields about 1.8% — still well below Chevron's roughly 3.8% and Exxon Mobil's 2.8%, a gap that reflects how recently Occidental could afford to return capital at all. The 8% increase this year signals management's confidence that the cash flow is durable rather than purely cyclical.
"The sale of OxyChem is an important milestone in the strategic transformation of our company and will enable us to further strengthen our balance sheet, accelerate shareholder returns and unlock high-return opportunities across our core oil and gas business," Hollub said on the company's third-quarter earnings call.
She had reason for confidence. In August 2025, after announcing four new divestitures, she said: "We are pleased with how we continue to strategically strengthen our portfolio, and it's rewarding to see those efforts drive debt reduction and create value for shareholders. We believe Occidental has the best assets in our history and we will continue to find opportunities to high-grade our portfolio and generate long-term value."
The Cyclical Tailwind and the Structural Problem
Here is the judgment the market has to make, and it is not a small one. Much of Occidental's repair has been cyclical: oil prices recovered, free cash flow followed, and debt got paid down. Cyclical fixes mean-revert. If crude falls back toward $60 a barrel, the $3 billion quarterly free cash flow compresses, the dividend looks less secure, and the narrative of a transformed company gets retested. The company's own guidance assumes a favorable price environment; roughly 85% of its targeted $4 billion in annual sustainable cash flow by 2030 is achievable at lower oil prices, but the remaining 15% — and the optionality beyond it — is not.
The structural argument is different, and it rests on three pillars. First, the asset base is genuinely better than it was. The Anadarko acquisition, for all its financial folly, delivered some of the best Permian inventory in the basin; the CrownRock deal, closed in August 2024, added more than 94,000 net acres in the Midland Basin and about 170,000 boe/d of production. Second, the capital structure is now fixed differently: with gross debt near its lowest level in seven years and interest costs reset lower, the company's break-even oil price has fallen structurally, not temporarily. Third, the portfolio is simpler. After OxyChem, Occidental is an oil-and-gas producer with a midstream and marketing arm — a business investors can underwrite on one set of assumptions rather than two.
Separating the two forces matters because they point to different conclusions. The cyclical reading says Occidental's stock has simply rerated with the oil market, and a $55 oil future would take it back down. The structural reading says the company has permanently lowered its cost of capital and its risk premium, and deserves a higher multiple even at a flat oil price. The evidence leans structural — but only if management does not repeat the original sin.
The Counter-Thesis: A New CEO, the Same Temptation
The strongest argument against the bullish case is not financial; it is behavioral. Occidental's problem was never a lack of assets. It was a decision, made at the top of a cycle in a competitive auction, to pay a strategic price for Permian acreage using short-term debt. The CrownRock deal — $10.8 billion in cash and stock, $9.1 billion of it new debt — showed that the appetite for leveraged Permian consolidation survived the Anadarko trauma. Hollub argued at the time that the industry was consolidating and Occidental had to keep pace; critics said the company was doing to itself, on a smaller scale, exactly what had nearly broken it.
Now Hollub is gone, and Richard Jackson takes over with a clean balance sheet and a board seat. His stated mandate is execution: "execute from the strong position and capabilities that we built under Vicki's leadership." The risk is that a strong position invites new ambitions — another bolt-on acquisition, another round of leverage justified by "high-return opportunities." The market has priced Occidental as if the acquisition era is over. If Jackson signals otherwise, the multiple will contract faster than any dividend increase can offset it.
There is also the Berkshire overhang. The preferred must be redeemed before buybacks resume in earnest, and Mizuho estimates the OxyChem proceeds will reduce net debt-to-EBITDA by about 0.5x, bringing leverage in line with peers. HSBC does not expect share repurchases to resume before 2029. For a stock that rallied 38% this year on balance-sheet repair, the next leg of the rerating requires either sustained high oil prices or a faster path to returning capital — and the preferred structure stands between shareholders and both.
What to Watch, and What Would Prove the Case Wrong
The base case is that Occidental spends the rest of 2026 and 2027 in disciplined mode: holding capital spending near $5.5 billion to $5.9 billion, retiring the remaining preferred stake gradually, raising the dividend modestly, and letting the Permian portfolio compound. Under that scenario, the stock trades as a leveraged call on oil with a falling risk premium, and the Anadarko legacy becomes a case study rather than a constraint.
The upside case requires oil to stay firm while the company accelerates preferred redemption. If Brent holds above $80 and annual free cash flow stays near $10 billion, Occidental could clear the Berkshire preferred ahead of schedule, resume buybacks, and force a genuine multiple expansion. The downside case is simpler: oil below $65 for an extended period, combined with any signal of renewed acquisition appetite, would compress both earnings and the multiple at once.
The falsifying signal is specific. If Occidental announces a bolt-on acquisition valued above $5 billion funded with new debt before the Berkshire preferred is fully redeemed, the structural-turnaround thesis is broken — it would show the discipline was a function of distress, not of governance. A second test: if WTI trades below $60 for two consecutive quarters while the dividend remains untouched, the claim that cash flow is now durable would fail.
Seven years ago, Occidental bought Anadarko because it believed the Permian was worth any price. Today, the company is worth more than it was then — market capitalization near $61 billion against a share price that spent years in the mid-$30s. The balance sheet has been repaired. The harder task is proving that the lesson, and not just the leverage, has been retired.
Explore more exclusive insights at nextfin.ai.
